ATE470667T1 - Neue benzothiazinonderivate und ihre verwendung als antibakterielle mittel - Google Patents

Neue benzothiazinonderivate und ihre verwendung als antibakterielle mittel

Info

Publication number
ATE470667T1
ATE470667T1 AT06743049T AT06743049T ATE470667T1 AT E470667 T1 ATE470667 T1 AT E470667T1 AT 06743049 T AT06743049 T AT 06743049T AT 06743049 T AT06743049 T AT 06743049T AT E470667 T1 ATE470667 T1 AT E470667T1
Authority
AT
Austria
Prior art keywords
antibacterial agents
new
benzothiazinone derivatives
derivatives
new benzothiazinone
Prior art date
Application number
AT06743049T
Other languages
English (en)
Inventor
Vadim Makarov
Stewart T Cole
Ute Moellmann
Original Assignee
Leibniz Inst Naturstoff Forsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leibniz Inst Naturstoff Forsch filed Critical Leibniz Inst Naturstoff Forsch
Application granted granted Critical
Publication of ATE470667T1 publication Critical patent/ATE470667T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT06743049T 2006-05-24 2006-05-24 Neue benzothiazinonderivate und ihre verwendung als antibakterielle mittel ATE470667T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2006/004942 WO2007134625A1 (en) 2006-05-24 2006-05-24 New benzothiazinone derivatives and their use as antibacterial agents

Publications (1)

Publication Number Publication Date
ATE470667T1 true ATE470667T1 (de) 2010-06-15

Family

ID=37595033

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06743049T ATE470667T1 (de) 2006-05-24 2006-05-24 Neue benzothiazinonderivate und ihre verwendung als antibakterielle mittel

Country Status (24)

Country Link
US (2) US7863268B2 (de)
EP (1) EP2029583B1 (de)
JP (1) JP5068813B2 (de)
KR (1) KR101314999B1 (de)
CN (1) CN101472922B (de)
AP (1) AP2444A (de)
AT (1) ATE470667T1 (de)
AU (1) AU2006343832B2 (de)
BR (1) BRPI0621693B8 (de)
CA (1) CA2652841C (de)
CR (1) CR10519A (de)
CY (1) CY1110769T1 (de)
DE (1) DE602006014885D1 (de)
DK (1) DK2029583T3 (de)
EA (1) EA015910B1 (de)
ES (1) ES2345902T3 (de)
IL (1) IL195453A (de)
MX (1) MX2008014958A (de)
NZ (1) NZ573833A (de)
PL (1) PL2029583T3 (de)
PT (1) PT2029583E (de)
SI (1) SI2029583T1 (de)
TN (1) TNSN08474A1 (de)
WO (1) WO2007134625A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101314999B1 (ko) 2006-05-24 2013-10-04 라이브니츠 인스티튜트 포 내추럴 프로덕트 리서치 앤드 인펙션 바이올로지 이.브이. 한스-크뇔-인스티튜트 (에이치케이아이) 신규한 벤조티아지논 유도체 및 그의 항균제로서의 용도
EP2020406A1 (de) * 2007-07-16 2009-02-04 Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. Hans-Knöll-Institut Neue antimikrobielle Verbindungen, ihre Synthese und ihre Verwendung zur Behandlung von Infektionen bei Säugetieren
WO2009100731A1 (en) 2008-02-13 2009-08-20 Universita' Degli Studi Di Pavia An effective new drug target for the treatment of tuberculosis
EP2380886A1 (de) 2010-04-23 2011-10-26 Vadim A. Makarov Verfahren zur Herstellung von 2-Aminosubstituierten 1,3-Benzothiazin-4-onen
EP2640712B1 (de) * 2010-11-19 2018-07-11 Ecole Polytechnique Fédérale de Lausanne (EPFL) 2-piperazin-1-yl-4h-1,3-benzothiazin-4-on-derivate und ihre verwendung zur behandlung von infektionen bei säugetieren
EP2468746A1 (de) 2010-12-23 2012-06-27 The University of Queensland Benzothiazinon Verbindungen und deren Verwendung gegen Tuberkulose
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
CN102276598B (zh) * 2011-05-27 2014-11-05 四川大学 苯并噻嗪硫酮衍生物及其制备方法和用途
CN102367239B (zh) * 2011-07-20 2015-10-28 沈阳药科大学 2-芳基-2,3-二氢-4h-1,3-苯并噻嗪-4-酮衍生物及其用途
EP2570413A1 (de) 2011-09-15 2013-03-20 The University Of Queensland Benzothiazinon-Derivate als Wirkstoffe gegen Tuberkulose
CN103508980B (zh) * 2012-06-14 2016-07-06 四川大学 苯并噻嗪-4-酮衍生物及其制备方法和用途
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
CN104211708B (zh) * 2013-05-29 2018-08-24 中国医学科学院药物研究所 苯并噁嗪酮衍生物及其作为抗菌剂的应用
WO2015038978A1 (en) 2013-09-13 2015-03-19 Symbolics, Llc Lateral flow assays using two dimensional test and control signal readout patterns
JP6412570B2 (ja) 2013-11-18 2018-10-24 グリロ‐ヴェルケ アーゲー アルカンおよび発煙硫酸からアルカンスルホン酸を製造するための新規な開始剤
DE102014012546A1 (de) * 2014-09-26 2016-03-31 Martin-Luther-Universität Halle-Wittenberg Antimykobakteriell wirksame Substanzen, Verfahren zu ihrer Herstellung und deren Verwendung
EP3072889A1 (de) * 2015-03-23 2016-09-28 Ecole Polytechnique Federale De Lausanne (Epfl) 2-homopiperazin-1-yl-4h-1,3-benzothiazin-4-on-derivate und verfahren zur herstellung von 2-(homo)piperazin 1,3-benzothiazin-4-on-hydrochloriden
CN105622596B (zh) * 2016-02-19 2018-10-30 浙江司太立制药股份有限公司 含有烷氧亚胺基氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法
CN105669664B (zh) * 2016-02-19 2019-05-10 浙江司太立制药股份有限公司 含有碱性氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法
US11155542B2 (en) 2016-09-22 2021-10-26 University Of Notre Dame Du Lac Antimicrobial compounds, their use for the treatment of mammalian infections and a new metabolic mechanism
RU2663848C1 (ru) * 2018-03-23 2018-08-10 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) 5-Фтор-2-(4-этоксикарбонилпиперазин-1-ил)-1,3-бензотиазин-4-он, обладающий противотуберкулезной активностью
CN111269197A (zh) * 2020-04-08 2020-06-12 苏州大学 苯并噻嗪酮化合物及其制备方法与作为抗结核药物的应用
CN113121521B (zh) * 2021-03-26 2022-11-04 苏州大学 6-位三氟甲基取代的苯并噻嗪酮衍生物及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470168A (en) * 1967-03-31 1969-09-30 American Home Prod 2-substituted-4h-1,3-benzothiazin-4-one derivatives
US3522247A (en) * 1967-11-07 1970-07-28 Pfizer & Co C 2-amino-6,7-disubstituted-4h-1,3-benzothiazine-4-ones as bronchodilators
GB8611617D0 (en) 1986-05-13 1986-06-18 Shell Int Research Fungicides
WO2000051992A1 (en) 1999-03-04 2000-09-08 E.I. Du Pont De Nemours And Company Fused bicyclic oxazinone and thiazinone fungicides
EP1312607A1 (de) 2001-11-17 2003-05-21 MEDAC GmbH Dithiocarbamat Derivate und deren Verwendung als bakterientötendes Mittel
WO2004060881A1 (ja) 2002-12-05 2004-07-22 Takeda Pharmaceutical Company Limited １，３−ベンゾチアジノン誘導体、その製造法および用途
US20090093468A1 (en) 2004-03-26 2009-04-09 Patrizia Cali Peptide Deformylase Inhibitors
KR101314999B1 (ko) 2006-05-24 2013-10-04 라이브니츠 인스티튜트 포 내추럴 프로덕트 리서치 앤드 인펙션 바이올로지 이.브이. 한스-크뇔-인스티튜트 (에이치케이아이) 신규한 벤조티아지논 유도체 및 그의 항균제로서의 용도

Also Published As

Publication number Publication date
JP5068813B2 (ja) 2012-11-07
EA200870564A1 (ru) 2009-06-30
EP2029583B1 (de) 2010-06-09
IL195453A0 (en) 2009-08-03
KR20090029736A (ko) 2009-03-23
PL2029583T3 (pl) 2010-10-29
DK2029583T3 (da) 2010-09-27
AP2008004723A0 (en) 2008-12-31
CR10519A (es) 2009-04-14
JP2009537576A (ja) 2009-10-29
CA2652841A1 (en) 2007-11-29
US20110160193A1 (en) 2011-06-30
CN101472922A (zh) 2009-07-01
AU2006343832A1 (en) 2007-11-29
ES2345902T3 (es) 2010-10-05
KR101314999B1 (ko) 2013-10-04
US20090239851A1 (en) 2009-09-24
NZ573833A (en) 2010-10-29
PT2029583E (pt) 2010-08-12
CN101472922B (zh) 2012-05-30
CA2652841C (en) 2015-01-27
AP2444A (en) 2012-08-31
TNSN08474A1 (en) 2010-04-14
US7863268B2 (en) 2011-01-04
CY1110769T1 (el) 2015-06-10
AU2006343832B2 (en) 2011-07-21
BRPI0621693A2 (pt) 2011-12-20
EP2029583A1 (de) 2009-03-04
BRPI0621693B1 (pt) 2020-11-17
MX2008014958A (es) 2009-04-15
BRPI0621693B8 (pt) 2021-05-25
IL195453A (en) 2013-01-31
DE602006014885D1 (de) 2010-07-22
WO2007134625A1 (en) 2007-11-29
EA015910B1 (ru) 2011-12-30
SI2029583T1 (sl) 2010-09-30

Similar Documents

Publication Publication Date Title
ATE470667T1 (de) Neue benzothiazinonderivate und ihre verwendung als antibakterielle mittel
ATE543825T1 (de) Spiro-oxindolverbindungen und ihre verwendungen als therapeutische mittel
ATE481406T1 (de) Pyrrolochinoxalinonderivate als antibakterielle mittel
ATE520681T1 (de) N-thioanthranilamidverbindungen und ihre verwendung als pestizide
ATE460417T1 (de) Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten
DE602007004220D1 (de) Neue pyridazinverbindung und ihre verwendung
ATE478059T1 (de) Cinnamoylpiperazinderivate und ihre verwendung als par-1-antagonisten
ATE472549T1 (de) Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel
ATE465163T1 (de) Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
DE602007012955D1 (de) Filter und Duplexer
ATE544752T1 (de) Aryloxyacetamidderivate und ihre verwendung als fungizide
DE602007006553D1 (de) Antibakterielle chinolinderivate
ATE493396T1 (de) Neue indazolcarboxamide und ihre verwendung
ATE387440T1 (de) Neue 4-benzylidenpiperidinderivate
ATE513817T1 (de) Pyrimidinderivate und ihre verwendung als pestizide
DE112007002683T8 (de) Farbmittelzusammensetzungen und ihre Verwendung als pH-empfindliche Farbindikatoren
ATE442366T1 (de) Oxazolidinonderivate und ihre verwendung als antibiotika
DE602007006540D1 (de) Cyclopropancarboxylate und deren verwendung als pestizide
ATE425167T1 (de) Neue pyridothienopyrimidinderivate
DE102007013751B8 (de) Tiefpassfilter und Tiefpassfilter-Anordnung
DE602007006231D1 (de) Antibakterielle chinolinderivate
DE602007010182D1 (de) Antibakterielle chinolinderivate
ATE500223T1 (de) Phenylpentadienoylderivate und ihre verwendung als par-1-antagonisten
ATE506365T1 (de) Neue verbindungen und ihre verwendung
ATE470661T1 (de) 5-aminoalkylpyrazolderivate als pestizide mittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2029583

Country of ref document: EP